Literature DB >> 10655362

Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture.

S D Vernon1, E R Unger, D Williams.   

Abstract

We compared the results of human papillomavirus (HPV) detection and typing from 781 cervical samples assayed by three methods: L1 consensus PCR followed by cycle sequencing, L1 consensus PCR with biotinylated primers followed by hybridization to a line blot, and Hybrid Capture assay. Both PCR assays used L1 consensus PCR with primers MY09 and MY11. We evaluated the amplification efficiencies of both PCR assays and also compared the specific HPV types detected by each method. The samples positive by the Hybrid Capture assay were compared to the specific types detected by the PCR-based assays. The concordance between the two PCR assays in producing an HPV amplicon visible by gel electrophoresis or in detecting any HPV type was moderate: kappa values were 0.61 (95% confidence interval [CI] = 0.56 to 0.67) and 0.51 (95% CI = 0.46 to 0.58), respectively. The McNemar test for correlated proportions indicated that biotinylated PCR was less likely to produce a band (P = 0.001) and to detect an HPV type (P = 0.001) than the other PCR assay. In comparing the Hybrid Capture assay results with the HPV types detected by the PCR-based assays, we found that positivity by the Hybrid Capture assay for a number of samples may be due to cross-hybridization with HPV types not included in the Hybrid Capture assay probe cocktails.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655362      PMCID: PMC86168     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  RNA virus genomes hybridize to cellular rRNAs and to each other.

Authors:  M A McClure; J Perrault
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

2.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

3.  Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. The Canadian Women's HIV study group.

Authors:  F Coutlée; P Gravitt; H Richardson; C Hankins; E Franco; N Lapointe; H Voyer
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

4.  Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.

Authors:  D G Harnish; L M Belland; E E Scheid; T E Rohan
Journal:  Mol Cell Probes       Date:  1999-02       Impact factor: 2.365

5.  Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer.

Authors:  E R Unger; S D Vernon; W W Thoms; R Nisenbaum; C O Spann; I R Horowitz; J P Icenogle; W C Reeves
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

6.  Using the polymerase chain reaction to genotype human papillomavirus DNAs in samples containing multiple HPVs may produce inaccurate results.

Authors:  R A Tucker; P R Johnson; W C Reeves; J P Icenogle
Journal:  J Virol Methods       Date:  1993-08       Impact factor: 2.014

7.  Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.

Authors:  C L Peyton; M Schiffman; A T Lörincz; W C Hunt; I Mielzynska; C Bratti; S Eaton; A Hildesheim; L A Morera; A C Rodriguez; R Herrero; M E Sherman; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

  7 in total
  38 in total

1.  Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples.

Authors:  K W Hart; O M Williams; N Thelwell; A N Fiander; T Brown; L K Borysiewicz; C M Gelder
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Viral and microbial genotyping by a combination of multiplex competitive hybridization and specific extension followed by hybridization to generic tag arrays.

Authors:  Baback Gharizadeh; Max Käller; Pål Nyrén; Anders Andersson; Mathias Uhlén; Joakim Lundeberg; Afshin Ahmadian
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

3.  Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.

Authors:  François Coutlée; Danielle Rouleau; Patrick Petignat; Georges Ghattas; Janet R Kornegay; Peter Schlag; Sean Boyle; Catherine Hankins; Sylvie Vézina; Pierre Coté; John Macleod; Hélène Voyer; Pierre Forest; Sharon Walmsley; Eduardo Franco
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  MassARRAY spectrometry is more sensitive than PreTect HPV-Proofer and consensus PCR for type-specific detection of high-risk oncogenic human papillomavirus genotypes in cervical cancer.

Authors:  Partha Basu; Puneet Chandna; R N K Bamezai; Maqsood Siddiqi; Dhananjaya Saranath; Adrian Lear; Sam Ratnam
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

5.  Development and clinical evaluation of a highly sensitive DNA microarray for detection and genotyping of human papillomaviruses.

Authors:  Tae Jeong Oh; Chang Jin Kim; Suk Kyung Woo; Tae Seung Kim; Dong Jun Jeong; Myung Soon Kim; Sunwoo Lee; Hyun Sill Cho; Sungwhan An
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

6.  Type-specific detection of 30 oncogenic human papillomaviruses by genotyping both E6 and L1 genes.

Authors:  Junping Peng; Lei Gao; Junhua Guo; Ting Wang; Ling Wang; Qing Yao; Haijun Zhu; Qi Jin
Journal:  J Clin Microbiol       Date:  2012-11-14       Impact factor: 5.948

7.  Validation of human papillomavirus genotyping by signature DNA sequence analysis.

Authors:  Sin Hang Lee; Veronica S Vigliotti; Jessica S Vigliotti; Suri Pappu
Journal:  BMC Clin Pathol       Date:  2009-05-22

8.  Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women--implications for vaccination.

Authors:  Richard A Moore; Gina Ogilvie; Daniel Fornika; Veronika Moravan; Marc Brisson; Mahsa Amirabbasi-Beik; Anita Kollar; Thomas Burgess; Ray Hsu; Laura Towers; Jane Lo; Jasenka Matisic; Angela Brooks-Wilson
Journal:  Cancer Causes Control       Date:  2009-05-29       Impact factor: 2.506

9.  Sensitive HPV detection in oropharyngeal cancers.

Authors:  David M Winder; Siolian L R Ball; Katie Vaughan; Nashat Hanna; Yin Ling Woo; Jürgen-Theodor Fränzer; Jane C Sterling; Margaret A Stanley; Holger Sudhoff; Peter K C Goon
Journal:  BMC Cancer       Date:  2009-12-15       Impact factor: 4.430

10.  Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens.

Authors:  Sin Hang Lee; Veronica S Vigliotti; Suri Pappu
Journal:  J Clin Pathol       Date:  2009-10-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.